![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response
Chromosomal region 1p22 is deleted in ⩾20% of multiple myeloma (MM) patients, suggesting the presence of an unidentified tumor suppressor. Using high-resolution genomic profiling, we delimit a 58 kb minimal de...
-
Article
Open AccessAssessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach
-
Article
Loss of CYLD expression unleashes Wnt signaling in multiple myeloma and is associated with aggressive disease
Deletion or mutation of the gene encoding the deubiquitinating enzyme CYLD is a common genomic aberration in multiple myeloma (MM). However, the functional consequence of CYLD loss and the mechanism underlying...
-
Article
Open AccessPharmacogenomics and chemical library screens reveal a novel SCFSKP2 inhibitor that overcomes Bortezomib resistance in multiple myeloma
While clinical benefit of the proteasome inhibitor (PI) bortezomib (BTZ) for multiple myeloma (MM) patients remains unchallenged, dose-limiting toxicities and drug resistance limit the long-term utility. The E...
-
Article
Open Access18F-fluoride-PET for dynamic in vivo monitoring of bone formation in multiple myeloma
Bone disease in multiple myeloma is characterized by reduced bone formation. The gold standard of bone formation is the mineral apposition rate (MAR), an invasive technique reflecting bone formation at a singl...
-
Article
Gene expression profile alone is inadequate in predicting complete response in multiple myeloma
With advent of several treatment options in multiple myeloma (MM), a selection of effective regimen has become an important issue. Use of gene expression profile (GEP) is considered an important tool in predic...
-
Article
Erratum: A gene expression signature for high-risk multiple myeloma
Correction to: Leukemia (2012) 26, 2406–2413; doi:10.1038/leu.2012.127 Since the publication of this article, the authors have discovered an error in the script for calculating the IFM-15 risk scores. In their...
-
Article
A gene expression signature for high-risk multiple myeloma
There is a strong need to better predict the survival of patients with newly diagnosed multiple myeloma (MM). As gene expression profiles (GEPs) reflect the biology of MM in individual patients, we built a pro...
-
Article
Open AccessVariation in the E2-binding domain of HPV 16 is associated with high-grade squamous intraepithelial lesions of the cervix
Human papillomaviruses (HPV) are strongly associated with cervical intraepithelial neoplasia (CIN) and invasive cancer mainly through the action of the E6 and E7 viral proteins, transcription of which is down-...
-
Chapter
Blends of polyamides and maleic-anhydride-containing polymers: interfacial chemistry and properties
Mixing two or more polymers usually results in phase separated systems, although molecularly miscible polymer blends are known too, some of them having economic importance. Blends of immiscible polymers offer att...
-
Chapter
Isolation and Characterization of Genes Involved in Mammalian Excision Repair
Repair of randomly occuring DNA injury in mammalian cells must require sophisticated and elaborative systems in view of the wide spectrum of different types of lesions that have to be recognized and removed, t...
-
Article
Molecular cloning of a human DNA repair gene
Cell strains derived from patients having a hereditary disorder associated with defects in repair of DNA damage such as xeroderma pigmentosum1,2 and mutants isolated from established rodent cell lines3,4 provide ...